Axiom Investors LLC Rhythm Pharmaceuticals, Inc. Put Options Transaction History
Axiom Investors LLC
- $11.8 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RYTM
# of Institutions
257Shares Held
64.5MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$671 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$557 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$553 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$485 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$357 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.54B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...